IMR Press / CEOG / Volume 31 / Issue 3 / pii/2004063

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report

Medical management of ectopic pregnancy with extremely high β-HCG levels: A case report

Show Less
1 Department of Obstetrics and Gynecology, Faculty of Medicine, Trakya University, Edrne (Turkey)
Clin. Exp. Obstet. Gynecol. 2004, 31(3), 242–243;
Published: 10 September 2004
Abstract

We report the successful treatment of an unruptured ectopic pregnancy in a patient with extremely high β-human choriomc gonadotropin concentrations. A 33-year-old woman, gravida 2, para 0, abortus I, presented to our department due to menstrual delay On transvaginal ultrasonography, she had an unruptured ectopic pregnancy (3.5 × 4.5 cm). Her initial β-HCG concentration was 38,270 mIU/mL. The administration of methotrexate (50 mg/m2) was performed intramuscularly. Serum β-HCG levels decreased >15% between post-therapy days 4 (31,324 mIU/mL) and 7 (13,108 mIU/mL), and did not rise during the subsequent weekly controls. In selected cases with unruptured ectopic pregnancy and extremely high initial β-HCG levels, medical management with a singledose methotrexate regimen may be successful.

Keywords
Unruptured ectopic pregnancy
Metholrexate
High β-HCG
Share
Back to top